{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:24:39Z","timestamp":1793287479592,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.tice.2022.101920","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T11:40:40Z","timestamp":1662464440000},"page":"101920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["New candidates in the differential diagnosis of malignant mesothelioma from benign mesothelial hyperplasia and adenocarcinoma; DARS2 and suprabasin"],"prefix":"10.1016","volume":"79","author":[{"given":"Ozlem","family":"Ucer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin","family":"Kocaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2022.101920_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5152\/ttd.2010.23","article-title":"Immunohistochemistry in the belief of pleural epithelioid malignant mesothelioma and adenocarcinoma; a panel","volume":"11","author":"Aky\u0131ld\u0131z","year":"2010","journal-title":"Turk. Thorac. J."},{"key":"10.1016\/j.tice.2022.101920_bib2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1089\/ars.2009.2737","article-title":"Epithelial-mesenchymal transition: From molecular mechanisms to redox regulation to implications in human health and disease","volume":"12","author":"Cannito","year":"2010","journal-title":"Antioxide Redox Signal"},{"key":"10.1016\/j.tice.2022.101920_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","article-title":"Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma","volume":"18","author":"Carbone","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.tice.2022.101920_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21037\/tlcr.2019.11.29","article-title":"Application of immunohistochemistry in diagnosis and management of malignant mesothelioma","volume":"9","author":"Chapel","year":"2020","journal-title":"Transl. Lung Cancer Res"},{"key":"10.1016\/j.tice.2022.101920_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1183\/16000617.0165-2020","article-title":"Mitochondrial dysfunction in lung aging and disease","volume":"29","author":"Cloonan","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.tice.2022.101920_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmet.2014.02.004","article-title":"Tissue-specific loss of DARS2 activates stress responses in the heart independent of respiratory chain deficiency","volume":"19","author":"Dogan","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tice.2022.101920_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.21037\/tlcr.2020.02.01","article-title":"How asbestos and other fibers cause mesothelioma","volume":"9","author":"Gaudino","year":"2020","journal-title":"Trance. Lung Cancer Res."},{"key":"10.1016\/j.tice.2022.101920_bib8","first-page":"1644","article-title":"Mitochondrial dysfunction induces invasive phenotype and cell migration and invasion in lung cancer cells through induction of AKT and AMPK pathways","volume":"42","author":"Han","year":"2018","journal-title":"Int. J. Mol. Med"},{"key":"10.1016\/j.tice.2022.101920_bib9","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00018-015-2122-9","article-title":"TUFM downregulation induces epithelial-mesenchymal transition and invasion in lung cancer cells through a mechanism involving AMPK-GSK 3\u03b2 signaling","volume":"73","author":"He","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.tice.2022.101920_bib10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ijc.31077","article-title":"Hand-swirled chrysotile exposure and risk of malignant mesothelioma: a case-control study in southeastern China","volume":"14","author":"Jiang","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tice.2022.101920_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/10520295.2019.1656344","article-title":"Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?","volume":"95","author":"Kocaman","year":"2020","journal-title":"Biotech. Histochem"},{"key":"10.1016\/j.tice.2022.101920_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5858\/2008-132-397-AOITTD","article-title":"Application of \u0130mmunohistochemistry to the diagnosis of malignant mesothelioma","volume":"132","author":"Marchevsky","year":"2008","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.tice.2022.101920_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygeno.2004.03.010","article-title":"Identification of novel keratinocyte-secreted peptides dermokine-\u03b1\/- \u03b2 and a new stratified epithelium-secreted protein gene complex on human chromosome 19q13.1","volume":"84","author":"Matsui","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.tice.2022.101920_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","article-title":"Malignant pleural mesothelioma: the standard of care and challenges for future management","volume":"78","author":"Meerbeeck","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.tice.2022.101920_bib15","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/hmg\/ddu612","article-title":"OXPHOS dysfunction regulates integrin-\u03b21 modifications and increases cell motility and migration","volume":"2","author":"Nunes","year":"2015","journal-title":"Hum. Mole. Genet"},{"key":"10.1016\/j.tice.2022.101920_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2006.08.010","article-title":"What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? a review and update","volume":"38","author":"Ordonez","year":"2007","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.tice.2022.101920_bib17","doi-asserted-by":"crossref","first-page":"45195","DOI":"10.1074\/jbc.M205380200","article-title":"Suprabasin, a novel epidermal differentiation marker and potential cornified envelope precursor","volume":"277","author":"Park","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tice.2022.101920_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/genes12010108","article-title":"Suprabasin-a review","volume":"12","author":"Pribyl","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.tice.2022.101920_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-017-0618-x","article-title":"Upregulation of DARS2 by HBV promotes hepatocarcinogenesis via the miR-30e-5p\/MAPK\/NFAT5 pathway","volume":"36","author":"Qin","year":"2017","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.tice.2022.101920_bib20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejcts.2009.08.027","article-title":"Prognostic significance of the epithelial-mesenchymal transition in malignant pleural mesenchymal transition","volume":"37","author":"Schramm","year":"2010","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.tice.2022.101920_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12094-013-1054-9","article-title":"Proteomic analysis of pleural efusion from lung adenocarcinoma patients by shotgun strategy","volume":"16","author":"Sheng","year":"2014","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.tice.2022.101920_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41598-021-03645-6","article-title":"A novel 14 gene signature for overall survival in lung adenocarcinoma based on the Bayes hierarchical Cox proportional hazards model","volume":"12","author":"Sun","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2022.101920_bib23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11033-021-06897-7","article-title":"Suprabasin: role in human cancers and other diseases","volume":"49","author":"Tan","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tice.2022.101920_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5146\/tjpath.2013.01158","article-title":"Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma","volume":"29","author":"Ucer","year":"2013","journal-title":"Turk. J. Pathol."},{"key":"10.1016\/j.tice.2022.101920_bib25","article-title":"Identification of the functions and prognostic values of RNA binding proteins in bladder cancer","volume":"22","author":"Wu","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.tice.2022.101920_bib26","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1073\/pnas.1006542107","article-title":"Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and consequent inflammation","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tice.2022.101920_bib27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","article-title":"Mitochondria and cancer","volume":"61","author":"Zong","year":"2016","journal-title":"Mole. Cell"}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816622001926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816622001926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:27:12Z","timestamp":1758572832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816622001926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":27,"alternative-id":["S0040816622001926"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2022.101920","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New candidates in the differential diagnosis of malignant mesothelioma from benign mesothelial hyperplasia and adenocarcinoma; DARS2 and suprabasin","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2022.101920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101920"}}